“(1) In General – In implementing the Medicare Advantage Value-Based Insurance Design model that is being tested under section 1115A(b), the Secretary shall revise the testing of the model under such section to cover, effective not later than January 1, 2020, all States.

“(2) Termination and Modification Provision Not Applicable Until January 1, 2022 – The provisions of section 1115(b)(3)(B) shall apply to the Medicare Advantage Value-Based Insurance Design model, including such model as revised under paragraph (1), beginning January 1, 2022, but shall not apply to such model, as so revised, prior to such date.

“(3) Funding – The Secretary shall allocate funds made available under section 1115(f)(1) to design, implement, and evaluate the Medicare Advantage Value-Based Insurance Design model, as revised under paragraph (1).”

The nationwide expansion of the CMS MA V-BID demonstration by January 1, 2020, demonstrates growing bipartisan support for the expanded role of V-BID principles in public and private payers including the TRICARE program, and most recently, the introduction of the Chronic Disease Management Act of 2018. This bipartisan bill provides high-deductible health plans the flexibility to provide coverage for services that manage chronic disease prior to meeting the plan deductible.

A. Mark Fendrick, MD, developer of the V-BID concept and Director of the University of Michigan V-BID Center, is available for questions or comments.

View the resources below to learn more about V-BID in Medicare Advantage.